CDK4 and ovarian carcinoma: Our previously published results [14] concerning the action of leptin receptor antagonists on epithelial ovarian cancer cells showed that both antagonists studied decreased cdk2 and cdk4 protein expression in CaOV-3 and OVCAR-3 cells.